menu
    • menu

    Company profile for Neucore Bio

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neucore Bio is an early-stage biotechnology company based in Columbus, Ohio, pioneering non-viral, engineered exosome delivery technologies for precision genetic medicine and advanced functional skincare. Leveraging its proprietary Fibroblast-Derived Engineering Extracellular Vesicles (FiXE™) platform, Neucore Bio enables targeted, scalable delivery of RNA-based therapeutics to address complex diseases of the peripheral nerv...
    Neucore Bio is an early-stage biotechnology company based in Columbus, Ohio, pioneering non-viral, engineered exosome delivery technologies for precision genetic medicine and advanced functional skincare. Leveraging its proprietary Fibroblast-Derived Engineering Extracellular Vesicles (FiXE™) platform, Neucore Bio enables targeted, scalable delivery of RNA-based therapeutics to address complex diseases of the peripheral nervous system and age-related skin degeneration. The company has secured funding from the U.S. National Science Foundation and the National Institutes of Health to advance its innovative therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neucore BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1275 Kinnear Road, Columbus, OH 43212
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neucorebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neucore-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neucore Bio Gets NIH STTR Ph I Grant For Exosome In CMT1A
    Neucore Bio Gets NIH STTR Ph I Grant For Exosome In CMT1A

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/neucore-bio-awarded-us-national-institutes-of-health-nih-sttr-phase-i-grant-to-pursue-exosome-ba

    PHARMAWEB
    02 Sep 2025
    Share Share
    Neucore Wins NSF Grant for Exosome-based Genetic Disease Research
    Neucore Wins NSF Grant for Exosome-based Genetic Disease Research

    06 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250806053524/en/Neucore-Bio-Awarded-Competitive-Grant-from-the-U.S.-National-Science-Foundation-NSF-for-Research-on-Scalability-of-Exosome-based-Therapeutics-for-Genetic-Disease

    BUSINESSWIRE
    06 Aug 2025
    Share Share
    ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading
    ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading

    18 Apr 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-04-18/exoxpert-neucore-bio-to-evaluate-advanced-exosome-loading/?widget=listSection

    CONTRACT PHARMA
    18 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search